PriceTargets.com logo

Shanghai Fosun Pharmaceutical (Group) - SFOSF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.30 As of 11/28/2025 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for SFOSF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Shanghai Fosun Pharmaceutical (Group) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SFOSF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SFOSF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Shanghai Fosun Pharmaceutical (Group) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.30.

This chart shows the closing price for SFOSF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Shanghai Fosun Pharmaceutical (Group). This rating has held steady since October 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/10/2023HSBCDowngradeBuy ➝ Hold
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.

Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Read More

Today's Range

Now: $3.30
Low: $3.30
High: $3.30

50 Day Range

MA: $3.31
Low: $3.30
High: $3.50

52 Week Range

Now: $3.30
Low: $1.62
High: $3.50

Volume

N/A

Average Volume

2,733 shs

Market Capitalization

N/A

P/E Ratio

2.82

Dividend Yield

1.21%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Shanghai Fosun Pharmaceutical (Group)?

The following Wall Street sell-side analysts have issued reports on Shanghai Fosun Pharmaceutical (Group) in the last twelve months:
View the latest analyst ratings for SFOSF.

What is the current price target for Shanghai Fosun Pharmaceutical (Group)?

0 Wall Street analysts have set twelve-month price targets for Shanghai Fosun Pharmaceutical (Group) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Shanghai Fosun Pharmaceutical (Group) in the next year.
View the latest price targets for SFOSF.

What is the current consensus analyst rating for Shanghai Fosun Pharmaceutical (Group)?

Shanghai Fosun Pharmaceutical (Group) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SFOSF.

What other companies compete with Shanghai Fosun Pharmaceutical (Group)?

Other companies that are similar to Shanghai Fosun Pharmaceutical (Group) include 1933 Industries, 4Cable TV International, 4Front Ventures, AB Science and Abacus Health Products. Learn More about companies similar to Shanghai Fosun Pharmaceutical (Group).

How do I contact Shanghai Fosun Pharmaceutical (Group)'s investor relations team?

Shanghai Fosun Pharmaceutical (Group)'s physical mailing address is Building A, Fosun Technology Park No. 1289 Yishan Road, Shanghai 200233, China. The company's listed phone number is 86-21-3398-7000. The official website for Shanghai Fosun Pharmaceutical (Group) is www.fosunpharma.com. Learn More about contacing Shanghai Fosun Pharmaceutical (Group) investor relations.